banner ad

Health Care Economist Consultant John Schneider

Dr. John E. Schneider, PhD
CEO & Founder
26 Washington Street
Floor 3
Morristown NJ 07960
USA
phone: 862-260-9191 or (Cell) 319-331-2122
John-Schneider-Logo.jpg
John Schneider John Schneider Health Care Economist Expert WitnessDr. John E. Schneider, PhD, CEO and Founder of Avalon Health Economics, is a Health Care Economist with over 25 years of experience. Dr. Schneider's expertise includes the Analysis of Medical Care Costs, Health Insurance and Managed Care, Regulation, Hospital Competition, Specialty Hospitals, Physician Ownership, Outcomes Research, Technology Assessment, Process Change, and Insurer / Provider Contracting. He serves as a Consultant to managed care organizations, state health departments, trade associations, medical device manufacturers, large pharmaceutical companies, and others.

Dr. Schneider is an adjunct faculty in the Department of Economics at Drew University and Faculty Affiliate of the Petris Center on Health Care Markets at the University of California Berkeley. His previous positions include Senior Director at Oxford Outcomes, Ltd., Principal and Senior Health Economist of Health Economics Consulting Group, LLC (which merged with Oxford Outcomes in late 2009), and Director of Research at the California Association of Health Plans.

Dr. Schneider’s research has been published in Health Affairs, Inquiry, Health Services Research, Medical Care Research and Review, International Journal of Health Care Financing and Economics, Review of Industrial Organization, International Journal of Technology Assessment in Health Care, Prevention Science, and Health Care Financing Review. He is often called upon for speaking engagements in his field of expertise. Dr. Schneider is also co-author of the book The Business of Health - The Role of Competition, Markets, and Regulation(AEI Press, 2006), in which he examines the influence of market competition and government regulation on hospitals, health insurance, managed care plans, and prescription drug advertising.

View Expert Witness Profile.
Robert Ohsfeldt, John Schneider
The Business of Health examines the influence of market competition and government regulation on hospitals, health insurance, managed care plans, and prescription drug advertising. Reformers must determine which components of the system are suitable for market competition and which would benefit from more direct government control.